Archon Partners’s Elevance Health ELV Stock Holding History

Archon Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,000	Closed	-$7.01M	–	43
2025 Q4	$7.01M	Hold	20,000	–	–	0.73%	38
2025 Q3	$6.46M	Hold	20,000	–	–	0.69%	35
2025 Q2	$7.78M	Sell	20,000 -30,000	-60%	-$12.1M	0.9%	31
2025 Q1	$21.7M	Sell	50,000 -15,000	-23%	-$6.02M	2.63%	15
2024 Q4	$24M	Hold	65,000	–	–	2.79%	14
2024 Q3	$33.8M	Hold	65,000	–	–	3.91%	9
2024 Q2	$35.2M	Hold	65,000	–	–	4.52%	6
2024 Q1	$33.7M	Hold	65,000	–	–	4.12%	7
2023 Q4	$30.7M	Hold	65,000	–	–	4.22%	6
2023 Q3	$28.3M	Hold	65,000	–	–	4.43%	6
2023 Q2	$28.9M	Hold	65,000	–	–	4.32%	6
2023 Q1	$29.9M	Hold	65,000	–	–	4.99%	4
2022 Q4	$33.3M	Hold	65,000	–	–	6.01%	3
2022 Q3	$29.5M	Hold	65,000	–	–	5.61%	4
2022 Q2	$31.4M	Hold	65,000	–	–	5.51%	4
2022 Q1	$31.9M	Hold	65,000	–	–	4.23%	6
2021 Q4	$30.1M	Hold	65,000	–	–	3.68%	7
2021 Q3	$24.2M	Hold	65,000	–	–	3.04%	10
2021 Q2	$24.8M	Hold	65,000	–	–	3.1%	8
2021 Q1	$23.3M	Hold	65,000	–	–	3.26%	10
2020 Q4	$20.9M	Buy	65,000 +2,000	+3%	+$614K	2.8%	12
2020 Q3	$16.9M	Buy	63,000 +3,000	+5%	+$807K	2.66%	14
2020 Q2	$15.8M	Hold	60,000	–	–	2.87%	14
2020 Q1	$13.6M	Hold	60,000	–	–	2.95%	12
2019 Q4	$18.1M	Hold	60,000	–	–	3.09%	10
2019 Q3	$14.4M	Hold	60,000	–	–	2.8%	12
2019 Q2	$16.9M	Hold	60,000	–	–	3.36%	8
2019 Q1	$17.2M	Hold	60,000	–	–	3.63%	5
2018 Q4	$15.8M	Hold	60,000	–	–	3.93%	4
2018 Q3	$16.4M	Hold	60,000	–	–	3.36%	7
2018 Q2	$14.3M	Hold	60,000	–	–	3.09%	7
2018 Q1	$13.2M	Hold	60,000	–	–	2.88%	8
2017 Q4	$13.5M	Hold	60,000	–	–	2.94%	9
2017 Q3	$11.4M	Hold	60,000	–	–	2.66%	11
2017 Q2	$11.3M	Hold	60,000	–	–	2.62%	13
2017 Q1	$9.92M	Hold	60,000	–	–	2.33%	21
2016 Q4	$8.63M	Hold	60,000	–	–	2.25%	22
2016 Q3	$7.52M	Sell	60,000 -3,000	-5%	-$387K	1.99%	30
2016 Q2	$8.27M	Sell	63,000 -1,000	-2%	-$137K	2.26%	24
2016 Q1	$8.89M	Sell	64,000 -25,000	-28%	-$3.34M	2.45%	21
2015 Q4	$12.4M	Hold	89,000	–	–	3.36%	5
2015 Q3	$12.5M	Hold	89,000	–	–	3.69%	4
2015 Q2	$14.6M	Hold	89,000	–	–	3.78%	1
2015 Q1	$13.7M	Hold	89,000	–	–	3.46%	1
2014 Q4	$11.2M	Hold	89,000	–	–	2.9%	6
2014 Q3	$10.6M	Buy	89,000 +240	+0.3%	+$27.5K	2.92%	5
2014 Q2	$9.55M	Buy	88,760 +260	+0.3%	+$26.8K	2.55%	10
2014 Q1	$8.81M	Buy	88,500 +3,680	+4%	+$333K	2.48%	11
2013 Q4	$7.84M	Buy	+84,820	New	+$7.54M	2.16%	22

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Archon Partners's ELV Position: Q1 2026 in Review

Archon Partners sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 20,000 shares — an estimated $7.01M sold.

Archon Partners first reported a position in ELV in Q4 2013 and held it in 49 quarters. The position peaked at $35.2M in Q2 2024. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Archon Partners reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
Archon Partners sold 20,000 Elevance Health shares in Q1 2026, an estimated $7.01M.
Archon Partners first reported a position in Elevance Health in Q4 2013 and held it in 49 quarters.
Archon Partners's Elevance Health position peaked at $35.2M in Q2 2024.
1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Archon Partners's 13F filing for Q1 2026, filed 15 May 2026.